Dr. Kari Stefansson and Dr. Paul Saunders Appointed to the Board
Irish life sciences company Genomics Medicine Ireland Ltd., has today announced the appointment of Dr. Kari Stefansson and Dr. Paul Saunders to its Board of Directors. The appointment will increase the size of the Genomics Medicine Ireland Board of Directors to six members. Read More
Genomics Medicine Ireland was featured in Silicon Republic’s 25 Interesting European AI start-ups to watch in 2017 as one of the Irish companies carrying the torch for this technology revolution.
Genomic information from thousands of people in Ireland may unearth new clues in the hunt for markers of disease and new medicines to treat them.
Read the recent interview with GMI co-founder, Dr. Sean Ennis, on AbbVie’s website.
GMI joins the battle to beat rare disorders in conjunction with Temple Street Hospital with our new study which kicked off yesterday. This issue was highlighted on The Pat Kenny Show yesterday morning featuring Professor Mary King and Angelina Ryan who is the mother of baby Ava whose life was cut short by a rare epilepsy. Listen in to the highlights from the programme to learn more.
Study Will Employ Advanced Technology to Explore Genetic Factors In Rare Conditions
Dublin, 28th February, 2017: Irish life-sciences company, Genomics Medicine Ireland Ltd. (GMI) has partnered with Temple Street Children’s University Hospital and the UCD Academic Centre on Rare Diseases (ACoRD) to launch a groundbreaking research study which will examine children with rare undiagnosed genetic disorders attending Temple Street, and their parents in order to identify the key genetic components of rare disorders. The study will combine advanced scientific technology in genomics, the study of all of a person’s genes, together with detailed clinical information to identify the genetic cause of rare disorders affecting/amongst families in Ireland. Read More
GMI co-founder, Dr. Sean Ennis, will be speaking at the national Rare Disease Day on Tuesday 28th February at the Royal Hospital Kilmainham, Dublin 8.
The event seeks to raise awareness of the impact that rare diseases have on the lives of patients and those who care for them. The theme of this year’s day is research.
Genomics Medicine Ireland CEO, Dan Crowley, will be sharing his views of the future at the “Making Digital Transformation Something Everyone Can Be a Part of” panel at the Dublin Tech Summit on Wednesday, 15th Feb at 16.30. The Dublin Tech Summit (DTS) is an international technology conference which is held at the Convention Centre Dublin in the city’s “Silicon Docks”.
DTS 2017 will bring together global leaders in innovation, technology and business to shape the future of global trends and technologies. MedTech is one of the eight core themes which participants will hear about from leaders shaping the future of industry. http://dublintechsummit.com/